US 8389557
Triazole derivatives useful as Axl inhibitors
granted A61PA61P13/12A61P15/00
Quick answer
US patent 8389557 (Triazole derivatives useful as Axl inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P13/12, A61P15/00, A61P17/06, A61P19/02